These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 23774012)
1. Treatment of PPROM with anhydramnion in humans: first experience with different amniotic fluid substitutes for continuous amnioinfusion through a subcutaneously implanted port system. Tchirikov M; Bapayeva G; Zhumadilov ZSh; Dridi Y; Harnisch R; Herrmann A J Perinat Med; 2013 Nov; 41(6):657-63. PubMed ID: 23774012 [TBL] [Abstract][Full Text] [Related]
2. Role of amnioinfusion in the management of premature rupture of the membranes at <26 weeks' gestation. Locatelli A; Vergani P; Di Pirro G; Doria V; Biffi A; Ghidini A Am J Obstet Gynecol; 2000 Oct; 183(4):878-82. PubMed ID: 11035330 [TBL] [Abstract][Full Text] [Related]
3. Treatment of Preterm Premature Rupture of Membranes with Oligo-/Anhydramnion Colonized by Multiresistant Bacteria with Continuous Amnioinfusion and Antibiotic Administrations through a Subcutaneously Implanted Intrauterine Port System: A Case Report. Tchirikov M; Zhumadilov Z; Winarno AS; Haase R; Buchmann J Fetal Diagn Ther; 2017; 42(1):71-76. PubMed ID: 26447923 [TBL] [Abstract][Full Text] [Related]
4. Premature rupture of the membranes at <26 weeks' gestation: role of amnioinfusion in the management of oligohydramnios. Vergani P; Locatelli A; Verderio M; Assi F Acta Biomed; 2004; 75 Suppl 1():62-6. PubMed ID: 15301294 [TBL] [Abstract][Full Text] [Related]
5. Long-term amnioinfusion through a subcutaneously implanted amniotic fluid replacement port system for treatment of PPROM in humans. Tchirikov M; Steetskamp J; Hohmann M; Koelbl H Eur J Obstet Gynecol Reprod Biol; 2010 Sep; 152(1):30-3. PubMed ID: 20488612 [TBL] [Abstract][Full Text] [Related]
6. Continuous amnioinfusion for treatment of mid-trimester preterm premature rupture of membranes with oligoamnios. Ono T; Tsumura K; Kawasaki I; Ikeda M; Hideshima M; Tsuda S; So K; Kawaguchi A; Nomiyama M; Yokoyama M J Obstet Gynaecol Res; 2020 Jan; 46(1):79-86. PubMed ID: 31650672 [TBL] [Abstract][Full Text] [Related]
7. Predictors of perinatal survival in a cohort of pregnancies with severe oligohydramnios due to premature rupture of membranes at <26 weeks managed with serial amnioinfusions. Locatelli A; Ghidini A; Verderio M; Andreani M; Strobelt N; Pezzullo J; Vergani P Eur J Obstet Gynecol Reprod Biol; 2006; 128(1-2):97-102. PubMed ID: 16530921 [TBL] [Abstract][Full Text] [Related]
8. Transabdominal amnioinfusion in preterm premature rupture of membranes: a randomised controlled trial. Tranquilli AL; Giannubilo SR; Bezzeccheri V; Scagnoli C BJOG; 2005 Jun; 112(6):759-63. PubMed ID: 15924533 [TBL] [Abstract][Full Text] [Related]
9. [The amnioinfusion therapy of saline solution for premature rupture of the membranes before 27 weeks' gestational age]. Horibe N; Ishikawa K; Kosaki H; Hashiba Y; Kuno N; Ito H; Miwa S; Ochi M; Fujimura Y; Kimura T Nihon Sanka Fujinka Gakkai Zasshi; 1993 Sep; 45(9):1023-9. PubMed ID: 8371017 [TBL] [Abstract][Full Text] [Related]
10. Test amnioinfusion to determine suitability for serial therapeutic amnioinfusion in midtrimester premature rupture of membranes. Tan LK; Kumar S; Jolly M; Gleeson C; Johnson P; Fisk NM Fetal Diagn Ther; 2003; 18(3):183-9. PubMed ID: 12711874 [TBL] [Abstract][Full Text] [Related]
11. Prophylactic transabdominal amnioinfusion in oligohydramnios for preterm premature rupture of membranes: increase of amniotic fluid index during latency period. Garzetti GG; Ciavattini A; De Cristofaro F; La Marca N; Arduini D Gynecol Obstet Invest; 1997; 44(4):249-54. PubMed ID: 9415523 [TBL] [Abstract][Full Text] [Related]
12. Amnioinfusion in very early preterm prelabor rupture of membranes (AMIPROM): pregnancy, neonatal and maternal outcomes in a randomized controlled pilot study. Roberts D; Vause S; Martin W; Green P; Walkinshaw S; Bricker L; Beardsmore C; Shaw N; McKay A; Skotny G; Williamson P; Alfirevic Z Ultrasound Obstet Gynecol; 2014 May; 43(5):490-9. PubMed ID: 24265189 [TBL] [Abstract][Full Text] [Related]
13. The experience of amnioinfusion for oligohydramnios during the early second trimester. Hsu TL; Hsu TY; Tsai CC; Ou CY Taiwan J Obstet Gynecol; 2007 Dec; 46(4):395-8. PubMed ID: 18182345 [TBL] [Abstract][Full Text] [Related]
14. Mid-trimester preterm premature rupture of membranes (PPROM): etiology, diagnosis, classification, international recommendations of treatment options and outcome. Tchirikov M; Schlabritz-Loutsevitch N; Maher J; Buchmann J; Naberezhnev Y; Winarno AS; Seliger G J Perinat Med; 2018 Jul; 46(5):465-488. PubMed ID: 28710882 [TBL] [Abstract][Full Text] [Related]
15. Treatment of mid-trimester preterm premature rupture of membranes (PPROM) with multi-resistant bacteria-colonized anhydramnion with continuous amnioinfusion and meropenem: a case report and literature review. Tchirikov M; Ocker R; Seliger G; Chaoui K; Moritz S; Haase R Arch Gynecol Obstet; 2022 Sep; 306(3):585-592. PubMed ID: 34791511 [TBL] [Abstract][Full Text] [Related]
16. Treatment of Classic Mid-Trimester Preterm Premature Rupture of Membranes (PPROM) with Oligo/Anhydramnion between 22 and 26 Weeks of Gestation by Means of Continuous Amnioinfusion: Protocol of a Randomized Multicentric Prospective Controlled TRIAL and Review of the Literature. Tchirikov M; Haiduk C; Tchirikov M; Riemer M; Bergner M; Li W; Henschen S; Entezami M; Wienke A; Seliger G Life (Basel); 2022 Aug; 12(9):. PubMed ID: 36143388 [TBL] [Abstract][Full Text] [Related]
17. Amnioinfusion for preterm premature rupture of membranes. Hofmeyr GJ; Essilfie-Appiah G; Lawrie TA Cochrane Database Syst Rev; 2011 Dec; (12):CD000942. PubMed ID: 22161365 [TBL] [Abstract][Full Text] [Related]
19. Amnioinfusion for third trimester preterm premature rupture of membranes. Hofmeyr GJ; Eke AC; Lawrie TA Cochrane Database Syst Rev; 2014 Mar; 2014(3):CD000942. PubMed ID: 24683009 [TBL] [Abstract][Full Text] [Related]
20. Amnioinfusion Compared With No Intervention in Women With Second-Trimester Rupture of Membranes: A Randomized Controlled Trial. van Kempen LEM; van Teeffelen AS; de Ruigh AA; Oepkes D; Haak MC; van Leeuwen E; Woiski M; Porath MM; Bax CJ; van Wassenaer-Leemhuis AG; Mulder AL; van der Ham DP; Willekes C; Franssen MT; Derks JB; Schuit E; Mol BW; Pajkrt E Obstet Gynecol; 2019 Jan; 133(1):129-136. PubMed ID: 30531572 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]